Issue 9/2019
Content (7 Articles)
Stroke
Current Opinion
Current Drug Treatment of Acute Ischemic Stroke: Challenges and Opportunities
Dafin F. Muresanu, Stefan Strilciuc, Adina Stan
Antipsychotics
Leading Article
Transdermal Delivery of Antipsychotics: Rationale and Current Status
Angela Abruzzo, Teresa Cerchiara, Barbara Luppi, Federica Bigucci
Status Epilepticus
Review Article
Recent Advances in the Drug Treatment of Dravet Syndrome
Elaine C. Wirrell, Rima Nabbout
Emerging Developments in Targeting Proteotoxicity in Neurodegenerative Diseases
Luke McAlary, Steven S. Plotkin, Neil R. Cashman
Apomorphine for Parkinson’s Disease: Efficacy and Safety of Current and New Formulations
Federico Carbone, Atbin Djamshidian, Klaus Seppi, Werner Poewe
An Integrated Safety Analysis of Infants and Children with Symptomatic Spinal Muscular Atrophy (SMA) Treated with Nusinersen in Seven Clinical Trials
Basil T. Darras, Michelle A. Farrar, Eugenio Mercuri, Richard S. Finkel, Richard Foster, Steven G. Hughes, Ishir Bhan, Wildon Farwell, Sarah Gheuens
Subjective Versus Objective Outcomes of Antipsychotics for the Treatment of Neuropsychiatric Symptoms Associated with Dementia
Eline J. Vredeveld, Tessa A. Hulshof, Sytse U. Zuidema, Hendrika J. Luijendijk